Search results
23andMe and Nightingale partner to pilot blood-based risk detection panel
Medical Device Network· 4 days agoThe test examines 36 genes using a saliva sample and can analyse the potential risk of up to 24...
Emcure Pharma IPO opens today: GMP rises; should you subscribe to the issue? - CNBC TV18
CNBC TV18· 2 days agoThe initial public offering (IPO) of Emcure Pharmaceuticals Ltd. opens for bidding on Wednesday,...
Ad-scam, lavish lies, and a billion-dollar fraud: How Rishi Shah’s Outcome Health duped high-profile...
Financial Express· 2 days agoThis high-profile case, reported by the Wall Street Journal, has drawn significant attention due to...
Travel: Finding traces of a globalised past in a Colombo cemetery
Livemint· 5 days agoThe Borella cemetery in Colombo could double as a sculpture garden. The funeral parlour for...
Obesity, diabetes drugs’ PLI scheme in India soon: Report
The Economic Times· 7 days agoThe anti-obesity medication market could reach $100 billion by 2030, according to a report by...
India to manufacture medication for diabetes, obesity under PLI by 2026: Report
Firstpost· 6 days agoIncentives are being planned by India in 2026 to encourage domestic production of GLP-1 medications,...
Namita Thapar-backed Emcure Pharma IPO kicks off: Should you subscribe to the issue?
Business Today· 2 days agoThe initial public offering (IPO) of Emcure Pharmaceuticals opens for bidding on Wednesday, July 3...
This Week in Explainers: Om Birla’s meteoric rise from MP to twice-elected Speaker
Firstpost· 6 days agoIt’s been a busy, busy week for India. From more revelations emerging from the NEET-UG exam exam...
Novo, Lilly fall after Biden calls for cheaper obesity drugs
CNBC Awaaz· 2 days agoNovo Nordisk A/S and Eli Lilly & Co. shares fell Tuesday after US President Joe Biden continued his...